Live Breaking News & Updates on Actym Therapeutics

Stay updated with breaking news from Actym therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Actym Therapeutics Appoints Thomas Smart as CEO

/PRNewswire/ Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive. ....

Berkeley , California , United-states , Chris-thanos , Thomas-smart , Sara-ortiz , Julie-cherrington , Cornell-university , Trophic-communications , Nasdaq , Genetics-institute , Pfizer

Actym Raises $59.5M In Series A funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Berkeley , California , United-states , Christopher-thanos , Boehringer-ingelheim-venture-fund , Actym-therapeutics , Illumina-ventures , Panacea-ventures ,

TOLREMO therapeutics Completes USD 39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest

TOLREMO therapeutics Completes USD 39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San-francisco , California , United-states , Steigen , Baden-wüberg , Germany , Stanford-university , France , French , Francesco-hofmann , Juliem-cherrington , Alison-opalko

Neurona Therapeutics Appoints James Stutz as Chief Financial Officer and Chief Business Officer

SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced the appointment of James Stutz, a business and finance executive with over 20 years of experience in the biopharma industry, as chief financial officer (CFO) and chief business officer (CBO). “We are delighted to welcome James to the Neurona team and look forward to the value he ....

United-states , Essex , California , James-stutz , Coryr-nicholas , Alios-biopharma , Elizabeth-wolffe , Sylvia-wheeler , Janssen-pharmaceutical-companies-of-johnson , Essex-woodlands-health-ventures , Strategic-decisions-group , University-of-california-at-santa-barbara

Adjuvant Pembrolizumab Continues to Provide Survival Benefit in Stage IIB/C Melanoma

Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma ....

Astellas-pharma , Immatics-incyte , Crown-bioscience , Jason-luke , Immunocore-incyte , Pembrolizumab-keytruda , Trex-bio , Codiak-biosciences , Bristol-myers-squibb , Serono , Novartis , Pfizer